Clinical Nutrition for Diabetes Care Market
Clinical Nutrition for Diabetes Care Market Trend, Opportunity, and Forecast Analysis, 2024-2032
Clinical Nutrition for Diabetes Care Market is segmented by Product, Stage, Sales Channel, and by Region. KDMI analyst foresees market revenue to cross USD 3.2 Billion by 2032 by growing with a CAGR of 4.9% during 2024-2032.
Clinical Nutrition for Diabetes Care Market Highlights
The global clinical nutrition for diabetes care market is expected to cross a value of USD 3.2 billion by the end of 2032. The market was valued at USD 2.1 billion in 2023 and is expected to expand at a CAGR of 4.9% between 2024-2032.
- Over the mid-term, the rise in demand for specialized food products among diabetic patients is the primary factor anticipated to drive the global clinical nutrition for diabetes care market.
- The lack of access to registered dietitians is a major factor to challenge the market growth.
- The North America clinical nutrition for diabetes care market is projected to dominate the global market.
Clinical Nutrition for Diabetes Care Market: Report Scope |
|
|
Base Year |
2023 |
|
Base Year Market Size |
USD 2.1 Billion |
|
Forecast Year |
2024-2032 |
|
Forecast Year Market Size |
USD 3.2 Billion |
|
CAGR Value |
4.9% |
|
Clinical Nutrition for Diabetes Care Market Key Trends/Major Growth Drivers |
|
|
Restraint Factors |
|
|
Clinical Nutrition for Diabetes Care Market Segmentation |
|
|
Clinical Nutrition for Diabetes Care Market Key Players |
Abbott Laboratories, Nestlé Health Science, Danone SA, Fresenius Kabi AG, Perrigo Company plc, B. Braun Melsungen AG, Medtronic plc, Glanbia plc, Novo Nordisk A/S, Sanofi, BD (Becton, Dickinson and Company), Nutricia (a subsidiary of Danone), and others. |
Clinical Nutrition for Diabetes Care Market Outlook
The specialized dietary interventions and nutritional strategies designed to manage blood sugar levels and prevent complications in individuals with diabetes is often known as clinical nutrition for diabetes care. The process of clinical nutrition for diabetes requires personalized nutrition assessment of the diabetic patient, and basis on the assessed results, counseling is provided by registered dietitians or healthcare professionals.
Our analysts at KD Market Insights predict that the rise in demand for specialized food products among diabetic patients is one of the primary factors to drive the growth of the global clinical nutrition for diabetes care market. Dietary modifications, such as carbohydrate counting, glycemic index management, and portion control, play a crucial role in controlling blood sugar levels and preventing spikes in glucose levels. As individuals with diabetes seek to optimize their dietary choices to better manage their condition, there is a growing demand for specialized clinical nutrition products and services tailored to their needs. Abbott Laboratories, Nestlé Health Science, and Danone SA are some of the significant parties in the global market for clinical nutrition for diabetes care.
Get More Insights on This Report - Request Free Sample PDF
Clinical Nutrition for Diabetes Care Market Drivers – Analyst’s Observation
According to the analysts at KD Market Insights, some key growth drivers for the global clinical nutrition for diabetes care market are:
- Surge in Prevalence of Diabetes: One of the most important factor expected to contribute to the growth of the global clinical nutrition for diabetes care market is the surge in prevalence of diabetes globally. The International Diabetes Federation (IDF) reported that globally 540 million people had diabetes, representing 10.5% of the adult population (20-79 years) in the year 2021. It also predicted that about 783 million people or 1 in 8 adults would be living with diabetes by 2045. This spur in growth recorded an increase of 46%. As diabetes rates continue to increase worldwide, there is a growing demand for effective nutrition interventions to manage blood sugar levels and prevent diabetes-related complications, which is projected to boost the market growth in the coming years.
- Rapid Ongoing Advancements in Clinical Nutrition: With the expanding healthcare industry, the research and development in clinical nutrition is also growing. Healthcare service providers and those associated with the treatment of diabetes are expanding their understanding on how diet and nutrition impact the management of diabetes. Hence, the increasing number of research studies on understanding and identifying specific dietary patterns, nutrients, and dietary supplements that can reduce insulin resistance as well as complications related to diabetes, and further improve glycemic control, are also expected to contribute to the growth of the market in the coming years.
Which Probable Factors Could Hamper the Growing Clinical Nutrition for Diabetes Care Market Trend?
As per our KD Market Insights analysis, some of the challenges expected to limit the global market growth of clinical nutrition for diabetes care are:
- Lack of Access to Registered Dietitians: Owing to the availability of less number of registered dietitians globally, especially in rural or underserved communities, diabetic individuals who are in need for personalized nutrition assessments, counseling and education for managing their condition effectively are severely impacted due to the lack of access to these registered dietitians. This lack of dietitians is therefore projected to hinder the market growth in the coming years.
- High Cost of Nutritional Counseling Services: The high cost of nutritional counseling services, which may be a barrier for some individuals as they lack adequate health insurance coverage or financial resources to afford out-of-pocket expenses, is also expected to limit the market growth in the coming years.
How is the Global Clinical Nutrition for Diabetes Care Market Segmented?
Our experts at KD Market Insights have segmented the global clinical nutrition for diabetes care market as:
|
By Product |
|
|
By Stage |
|
|
By Sales Channel |
|
|
By Region |
|
What are the Probable Factors Influencing the North America Clinical Nutrition for Diabetes Care Market Forecast?
The North America clinical nutrition for diabetes care market is majorly driven by the growing focus of the government of the nations in the region to treat diabetes as the United States alone registered 38.4 million people of all ages having diabetes as of 2021. Besides this, with the rising burden of chronic diseases, including diabetes in North America, there is a growing emphasis on preventive healthcare and early intervention strategies in the region, which is also expected to create opportunities for market growth.
As per our analysts at KD Market Insights, the following five players lead the North America clinical nutrition for diabetes care market growth:
- Abbott Laboratories
- Nestlé Health Science
- Medtronic plc
- Perrigo Company plc
- BD (Becton, Dickinson and Company)
|
Key Countries to Watch for in North America Clinical Nutrition for Diabetes Care Market |
Key Insights |
|
United States Clinical Nutrition for Diabetes Care Market to Register the Largest Regional Market Share |
USD 0.9 Billion |
|
Canada Clinical Nutrition for Diabetes Care Market to Grow with the Highest CAGR During 2024-2032 |
5.3% |
Which Key Players Top the Global Clinical Nutrition for Diabetes Care Market Share?
As per our analysts at KD Market Insights, the competitive landscape of global clinical nutrition for diabetes care market facilitates our readers in identifying their closest competitors. The manufacturers who are associated with clinical nutrition for diabetes care market are raising their focus on expanding their presence, as well as their market share. The market has also been witnessing an upward movement in the number of collaborations between research institutions and key players, aimed at introducing advanced technologies and innovation of new products. Here is a list of the key players who top the global clinical nutrition for diabetes care market share:
- Abbott Laboratories
- Nestlé Health Science
- Danone SA
- Fresenius Kabi AG
- Perrigo Company plc
- B. Braun Melsungen AG
- Medtronic plc
- Glanbia plc
- Novo Nordisk A/S
- Sanofi
- BD (Becton, Dickinson and Company)
- Nutricia (a subsidiary of Danone)
What are the Recent Developments Observed in the Clinical Nutrition for Diabetes Care Market?
Over the years, the experts at KD Market Insights have been observing the recent developments associated with global clinical nutrition for diabetes care market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful of key strategies including new product launches, mergers & acquisitions, and collaborations.
For instance, Fresenius Kabi stated that it has launched the Vasopressin injection, helpful to treat adults with vasodilatory shock.
Further, Danone India announced that it has introduced Protinex Diabetes Care in India. The launch of the product is targeted to all the individuals in the country who are suffering from diabetes.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
- Publication date: 16th March 2024
- Base year: 2022
- Forecast year: 2023-2033
- Format: PDF, PPT,Word,Excel
- Quick Contact -
- ISO Certified Logo -
Frequently Asked Questions(FAQ)
Clinical Nutrition for Diabetes Care Market
-: Our Clients :-
